The Guardian: Trump’s cannabis reform would revolutionise US policy. Just don’t expect the ‘war on drugs’ to end | Cannabis Law Report | Where to order Skittles Moonrock online

Learn where to order Skittles Moonrock online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

For decades, the issue of cannabis reform was firmly viewed as a leftist pipe dream. To most conservatives, particularly US Republicans, legalising weed was as realistic as nuclear disarmament, or abolishing national borders.

Think of the phrase “war on drugs” and the first people that probably come to mind are Republican presidents Nixon, Reagan and George HW and George W Bush. Although the clampdown reached its harshest levels during the presidency of Mr “I didn’t inhale” Bill Clinton, it always seemed as if the GOP owned the position of being “tough on drugs”. As recently as 2023, Mitch McConnell, then Senate Republican leader, reaffirmed this reputation by stating that: “Democrats are struggling with the basics. This should not be this hard. Drugs belong off our streets.”

Yet it now seems that the biggest change to US federal drug policy for more than 50 years will happen through a Republican president. On Monday, Donald Trump confirmed the rumours that he is “very strongly” considering rescheduling cannabis (or marijuana, as it is still called in US state documents, due to an early-20th-century drive to emphasise the plant’s foreignness) from Schedule I in the Controlled Substances Act – where its currently sits alongside heroin – to Schedule III, next to drugs such as codeine.

This change has been a long time coming. The Department of Health and Human Services recommended rescheduling back in 2023, and speculation that action was imminent had been building since August, when Trump said he was “looking into” this issue. But it is still a bold move, and one that could help Trump’s floundering popularity ahead of the midterms.

Despite the controversy that still surrounds this drug, cannabis rescheduling is well-supported by the US population. When public comment was invited on the proposed rescheduling, nearly 43,000 people submitted comments, with almost 70% calling for rescheduling – a record. Having cannabis classified as a Schedule I drug – ie a substance with no acceptable medical use and high potential for abuse – looks like an increasingly absurd position in a country where 40 out of 50 states have active medical cannabis programmes and 24 states have even legalised cannabis for recreational use.

Yet Trump’s actions are seemingly mired in contradiction. Just this month, Trump was re-energising the “war on drugs” by threatening to escalate his recent bombing raids on Venezuelan and Colombian shipping vessels he accuses of trafficking drugs. He has described the presidents of these countries as narcotics traffickers and, in September, he used his address to the UN to send a message: “To every terrorist thug smuggling poisonous drugs into the United States of America, please be warned that we will blow you out of existence.” Why is Donald Trump softening drug laws at home while ramping up the drug war abroad?

Read More

https://www.theguardian.com/commentisfree/2025/dec/16/trump-cannabis-reform-war-on-drugs